Surgical management of early stage cervical cancer: Ten years experience from one Greek health region

Purpose of investigation: Cervical cancer is the second most common malignancy in women, in both incidence and mortality. In the present study, we report our results of treating 93 consecutive patients with early invasive cervical cancers (Stages I-IIA).

Methods: The patients of this study comprised all women recognized with stage I-IIA cervical cancer during 1991-2000. Patients with stage IA1 cervical cancer without lymphvascular space involvement underwent either conservative management by means of large loop conization or simple hysterectomy. The remaining patients underwent radical hysterectomy and lymphadenectomy or radiation therapy. Mean (+/- SD) duration of follow-up was 6 (+/- 1.7) years.

Results: The mean (+/- SD) age of patients with stage I-IIA cervical cancer was 41.3 (+/- 9.1) year. Thirty-five patients with stage [A1 disease were managed conservatively with loop excision and 19 patients subsequently became pregnant. Fifty-two patients with stage IA2, IB and IIA cervical carcinoma underwent radical hysterectomy and lymphadenectomy.

Conclusion: Young women with stage IA1 cervical carcinoma wishing future fertility who undergo loop excision have a 100% cure rate. Women with stage IA2, IB, and IIA cervical cancer should undergo radical hysterectomy and lymphadenectomy or radiation therapy.

Cervical cancer; Microinvasion; Loop conization; Fert山ty; Radical hysterectomy; Lymphadenectomy

[1] National Institutes of Health Consensus Development Conference Statement on Cervical Cancer. Gynecol. Oncol., 1997, 66, 351.

[2] paraskevaidis E., Kitchener H. C., Miller I. D., Mann E., Jandial L., Fisher P. M.: "A population based study of microinvasive disease of the cervix. A colposcopic and cytologic analysis Gynecol. Oncol., 1992, 45, 9.

[3] Macleod A., Kitchener H. C., Parkin D. E., Sarkar T., Miller I. D., Mann E. et al.: "Cervical carcinoma in the Grampian region (1980-1991): a population-based study of survival and cervical cytology history". Br. J. Ohstet. Gynaecol., 1994, 101 (Suppl 9), 797.

[4] Shepherd J. H.: "Cervical and vulva cancer: changes in FIGO definitions of staging". Br. J. Ohstet. Gynaecol.,1996, 103, 405.

[5] FIGO news. "Modifications in the staging for stage I vulvar and stage I cervical cancer: report of the FIGO Committee on Gynecologic Oncology". Int. J. Gynecol. Ohstet., 1995, 50, 215.

[6] Paraskevaidis E.,K itchener H. C., Kalantaridou S. N.,A gnanti N., Lolis D. E.: "Large loop conization for early invasive cervical cancer". Int. J. Gynecol. Cancer, 1997, 7, 95.

[7] Donato D. M.: "Surgical management of stage TB-TIA cervical carcinoma". Semin. Surg. Oncol., 1999, 16, 232.

[8] Sugimori H., Iwasaka T., Yoshimura T., Tsukamoto N.: "Cytology of microinvasive squamous cell carcinoma of the uterine cervix" Acta Cytol., 1986, 31, 412.

[9] Prendiville W.: "Large loop excision of the transformation zone" Bailliere's Clin. Ohstet. Gynaecol., 1995, 9, 189.

[10] Peters W. A. 3rd,L iu P. Y.,B arrett R. J. 2nd,S tock R. J., Monk B J., Berek J. S. et al.: "Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix". J. Clin. Oneal., 2000, 18, 1606.

[11] Creasman W. T., Fetter B. F., Clarke-Pearson D. L., Kaufmann L., Parker R. T.: "Management of stage TA carcinoma of the cervix". Am. J. Ohstet. Gynecol., 1986, 153, 164.

[12] Delgado G.,B undy B.,Z aino R.,S evin B.,C reasman W. T., Major F.: "Prospective surgical-pathological study of disease-free interval in patients with stage TB squamous cell carcinoma of the cervix: A gynecologic oncology group study". Gynecol. Oncol., 1990, 38, 352.

[13] Berman M. L.,B ergen S.,S alazar H.: "Influence of histologic features and treatment on the prognosis of patient、with cervical cancer metastatic to pelvic lymph nodes". Gynecol. Oncol., 1990, 39, 127.

[141 Alvarez R. D., Potter M. E., Soong S., Gay F. L., Hatch K. D., Patridge E. E. et al.: "Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage 1B cervical cancer patients". Gynecol. Oncol., 1991, 43, 108.

[15] Brewster W.R.,M onk B. J.,Z iogas A.,A nton-Culver H.,Yamada S. D., Berman M. L.: "Intent-to-treat analysis of stage lb and Ila cervical cancer in the United States: radiotherapy or surgery 1988-I995". Ohstet. Gynecol.. 2001, 97, 248.

[16] Koh W. J., Panwala K., Greer B.: "Adjuvant therapy for high risk, early stage cervical cancer". Semin. Radiat. Oncol., 2000, 10, 51.

[17] Estape R. E., Angioli R., Madrigal M., Janicek M., Gomez C., Penalver M. et al.: "Close vaginal margins as a prognostic factor after radical hysterectomy". Gynecol. Oncol., 1998, 68, 229.

[18] Samlal R. A. K., Van der Velden J., Ten Kate F. J. W., Schilthms M. S.. Hart A. A., Lammes F. B.: "Surgical pathologic factors that predict recurrence in stage 1B and HA cervical carcinoma patients with negative lymph nodes". Cancer, 1997, 80, 1234.